P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro

European Journal of Neuroscience

Volumn 33, Issue 12, 2011, Pages 2203-2215

  Traini, Chiara ^a   Pedata, Felicita ^a   Cipriani, Sara ^a   Mello, Tommaso ^a   Galli, Andrea ^a   Giovannini, Maria Grazia ^a   Cerbai, Francesca ^a   Volpini, Rosaria ^b   Cristalli, Gloria ^b   Pugliese, Anna Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Anoxic depolarization; ATP receptors; Cerebral ischemia; Mitogen activated protein kinase; Synaptic potentials

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GLUCOSE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PURINERGIC P2 RECEPTOR; PURINERGIC P2 RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; IMMUNOBLOTTING; IN VITRO STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CELL HYPOXIA; EXCITATORY POSTSYNAPTIC POTENTIALS; HYPOGLYCEMIA; ISCHEMIA; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE DEGENERATION; PURINERGIC P2 RECEPTOR ANTAGONISTS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 79959355569     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07667.x     Document Type: Article

References (84)

1. Abbracchio, M.P., Burnstock, G., Verkhratsky, A. & Zimmermann, H. (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci., 32, 19-29.
2. Agell, N., Bachs, O., Rocamora, N. & Villalonga, P. (2002) Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell. Signal., 14, 649-654.
3. Anderson, W.W. & Collingridge, G.L. (2001) The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods, 108, 71-83.
4. Barbieri, R., Alloisio, S., Ferroni, S. & Nobile, M. (2008) Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases. Neurochem. Int., 53, 255-262.
5. Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S.S., Manning, A.M. & Anderson, D.W. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA, 98, 13681-13686.
6. Borsello, T. & Forloni, G. (2007) JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharm. Des., 13, 1875-1886.
7. Borsello, T., Clarke, P.G., Hirt, L., Vercelli, A., Repici, M., Schorderet, D.F., Bogousslavsky, J. & Bonny, C. (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med., 9, 1180-1186.
8. Camaioni, E., Boyer, J.L., Mohanram, A., Harden, T.K. & Jacobson, K.A. (1998) Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. J. Med. Chem., 41, 183-190.
9. Cavaliere, F., Florenzano, F., Amadio, S., Fusco, F.R., Viscomi, M.T., D'Ambrosi, N., Vacca, F., Sancesario, G., Bernardi, G., Molinari, M. & Volonte, C. (2003) Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience, 120, 85-98.
10. Chow, A.K., Thompson, C.S., Hogan, M.J., Banner, D., Sabourin, L.A. & Hakim, A.M. (2002) Cortical spreading depression transiently activates MAP kinases. Brain Res. Mol. Brain Res., 99, 75-81.
11. Christian, S.L., Ross, A.P., Zhao, H.W., Kristenson, H.J., Zhan, X., Rasley, B.T., Bickler, P.E. & Drew, K.L. (2008) Arctic ground squirrel (Spermophilus parryii) hippocampal neurons tolerate prolonged oxygen-glucose deprivation and maintain baseline ERK1/2 and JNK activation despite drastic ATP loss. J. Cereb. Blood Flow Metab., 28, 1307-1319.
12. Ciana, P., Fumagalli, M., Trincavelli, M.L., Verderio, C., Rosa, P., Lecca, D., Ferrario, S., Parravicini, C., Capra, V., Gelosa, P., Guerrini, U., Belcredito, S., Cimino, M., Sironi, L., Tremoli, E., Rovati, G.E., Martini, C. & Abbracchio, M.P. (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J., 25, 4615-4627.
13. Coppi, E., Pugliese, A.M., Stephan, H., Muller, C.E. & Pedata, F. (2007) Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signal., 3, 203-219.
14. Di Virgilio, F. (2007) Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci., 28, 465-472.
15. Domercq, M., Brambilla, L., Pilati, E., Marchaland, J., Volterra, A. & Bezzi, P. (2006) P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins. J. Biol. Chem., 281, 30684-30696.
16. Domercq, M., Perez-Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O. & Matute, C. (2010) P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia, 58, 730-740.
17. Farkas, E., Pratt, R., Sengpiel, F. & Obrenovitch, T.P. (2008) Direct, live imaging of cortical spreading depression and anoxic depolarisation using a fluorescent, voltage-sensitive dye. J. Cereb. Blood Flow Metab., 28, 251-262.
18. Fellin, T., Pozzan, T. & Carmignoto, G. (2006) Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J. Biol. Chem., 281, 4274-4284.
19. Ferrari, D., Los, M., Bauer, M.K., Vandenabeele, P., Wesselborg, S. & Schulze-Osthoff, K. (1999) P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett., 447, 71-75.
20. Franke, H., Krugel, U., Grosche, J., Heine, C., Hartig, W., Allgaier, C. & Illes, P. (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience, 127, 431-441.
21. Frenguelli, B.G., Wigmore, G., Llaudet, E. & Dale, N. (2007) Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem., 101, 1400-1413.
22. Ginet, V., Puyal, J., Magnin, G., Clarke, P.G. & Truttmann, A.C. (2009) Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia. J. Neurochem., 108, 552-562.
23. Greengard, P., Valtorta, F., Czernik, A.J. & Benfenati, F. (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science, 259, 780-785.
24. Grewal, S.S., York, R.D. & Stork, P.J. (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol., 9, 544-553.
25. Gupta, S., Barrett, T., Whitmarsh, A.J., Cavanagh, J., Sluss, H.K., Derijard, B. & Davis, R.J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15, 2760-2770.
26. Henriksson, M., Stenman, E., Vikman, P. & Edvinsson, L. (2007) MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia. Exp. Brain Res., 178, 470-476.
27. Hirt, L., Badaut, J., Thevenet, J., Granziera, C., Regli, L., Maurer, F., Bonny, C. & Bogousslavsky, J. (2004) D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke, 35, 1738-1743.
28. Irving, E.A. & Bamford, M. (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab., 22, 631-647.
29. Jang, I.S., Rhee, J.S., Kubota, H., Akaike, N. & Akaike, N. (2001) Developmental changes in P2X purinoceptors on glycinergic presynaptic nerve terminals projecting to rat substantia gelatinosa neurones. J. Physiol., 536, 505-519.
30. Jarvis, M.F., Burgard, E.C., McGaraughty, S., Honore, P., Lynch, K., Brennan, T.J., Subieta, A., Van Biesen, T., Cartmell, J., Bianchi, B., Niforatos, W., Kage, K., Yu, H., Mikusa, J., Wismer, C.T., Zhu, C.Z., Chu, K., Lee, C.H., Stewart, A.O., Polakowski, J., Cox, B.F., Kowaluk, E., Williams, M., Sullivan, J. & Faltynek, C. (2002) A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl Acad. Sci. USA, 99, 17179-17184.
31. Jiang, L.H., Mackenzie, A.B., North, R.A. & Surprenant, A. (2000) Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol. Pharmacol., 58, 82-88.
32. Jourdain, P., Bergersen, L.H., Bhaukaurally, K., Bezzi, P., Santello, M., Domercq, M., Matute, C., Tonello, F., Gundersen, V. & Volterra, A. (2007) Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci., 10, 331-339.
33. Jovanovic, J.N., Benfenati, F., Siow, Y.L., Sihra, T.S., Sanghera, J.S., Pelech, S.L., Greengard, P. & Czernik, A.J. (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc. Natl Acad. Sci. USA, 93, 3679-3683.
34. Kawamura, M., Gachet, C., Inoue, K. & Kato, F. (2004) Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice. J. Neurosci., 24, 10835-10845.
35. Kharlamov, A., Jones, S.C. & Kim, D.K. (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp. Brain Res., 147, 353-359.
36. Kim, M., Jiang, L.H., Wilson, H.L., North, R.A. & Surprenant, A. (2001) Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J., 20, 6347-6358.
37. Klapperstuck, M., Buttner, C., Bohm, T., Schmalzing, G. & Markwardt, F. (2000) Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes. Biochim. Biophys. Acta, 1467, 444-456.
38. Lammer, A., Gunther, A., Beck, A., Krugel, U., Kittner, H., Schneider, D., Illes, P. & Franke, H. (2006) Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur. J. Neurosci., 23, 2824-2828.
39. Lecca, D., Trincavelli, M.L., Gelosa, P., Sironi, L., Ciana, P., Fumagalli, M., Villa, G., Verderio, C., Grumelli, C., Guerrini, U., Tremoli, E., Rosa, P., Cuboni, S., Martini, C., Buffo, A., Cimino, M. & Abbracchio, M.P. (2008) The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS ONE, 3, e3579.
40. Madl, J.E. & Burgesser, K. (1993) Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J. Neurosci., 13, 4429-4444.
41. Malarkey, E.B. & Parpura, V. (2008) Mechanisms of glutamate release from astrocytes. Neurochem. Int., 52, 142-154.
42. Matute, C., Torre, I., Perez-Cerda, F., Perez-Samartin, A., Alberdi, E., Etxebarria, E., Arranz, A.M., Ravid, R., Rodriguez-Antiguedad, A., Sanchez-Gomez, M. & Domercq, M. (2007) P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci., 27, 9525-9533.
43. Melani, A., Turchi, D., Vannucchi, M.G., Cipriani, S., Gianfriddo, M. & Pedata, F. (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem. Int., 47, 442-448.
44. Melani, A., Gianfriddo, M., Vannucchi, M.G., Cipriani, S., Baraldi, P.G., Giovannini, M.G. & Pedata, F. (2006) The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res., 1073-1074, 470-480.
45. Namura, S., Iihara, K., Takami, S., Nagata, I., Kikuchi, H., Matsushita, K., Moskowitz, M.A., Bonventre, J.V. & Alessandrini, A. (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl Acad. Sci. USA, 98, 11569-11574.
46. North, R.A. (2002) Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
47. Nozaki, K., Nishimura, M. & Hashimoto, N. (2001) Mitogen-activated protein kinases and cerebral ischemia. Mol. Neurobiol., 23, 1-19.
48. Pankratov, Y., Castro, E., Miras-Portugal, M.T. & Krishtal, O. (1998) A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. Eur. J. Neurosci., 10, 3898-3902.
49. Panmand, D.S., Dal Ben, D., Giacobbe, D., Lambertucci, C., Marucci, G., Volpini, R., Nistri, A. & Cristalli, G. (2010) Substituted adenine derivatives as novel P2X3 receptor ligands. Purinergic Signal., 6, 6-49.
50. 1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro. J. Neurochem., 97, 1357-1368.
51. Pedata, F., Latini, S., Pugliese, A.M. & Pepeu, G. (1993) Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neurochem., 61, 284-289.
52. Philpott, K.L. & Facci, L. (2008) MAP kinase pathways in neuronal cell death. CNS Neurol. Disord. Drug Targets, 7, 83-97.
53. Pubill, D., Dayanithi, G., Siatka, C., Andres, M., Dufour, M.N., Guillon, G. & Mendre, C. (2001) ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. Cell Calcium, 29, 299-309.
54. Pugliese, A.M., Latini, S., Corradetti, R. & Pedata, F. (2003) Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br. J. Pharmacol., 140, 305-314.
55. Pugliese, A.M., Coppi, E., Spalluto, G., Corradetti, R. & Pedata, F. (2006) A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro. Br. J. Pharmacol., 147, 524-532.
56. Pugliese, A.M., Coppi, E., Volpini, R., Cristalli, G., Corradetti, R., Jeong, L.S., Jacobson, K.A. & Pedata, F. (2007) Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration. Biochem. Pharmacol., 74, 768-779.
57. Pugliese, A.M., Traini, C., Cipriani, S., Gianfriddo, M., Mello, T., Corradetti, R., Galli, A. & Pedata, F. (2009a) Role of purinergic P2 receptors on neuronal survival and MAPK activation during oxygen-glucose deprivation in the rat CA1 hippocampus. Program No. 52.13/J1 Neuroscience Meeting Planner. Society for Neuroscience, Chicago, IL.
58. Pugliese, A.M., Traini, C., Cipriani, S., Gianfriddo, M., Mello, T., Giovannini, M.G., Galli, A. & Pedata, F. (2009b) The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices. Br. J. Pharmacol., 157, 818-830.
59. Pugliese, A.M., Traini, C., Marangoni, M., Cipriani, S. & Pedata, F. (2010) Role of purinergic P2 receptors on neuronal survival and ERK1/2 activation after oxygen-glucose deprivation in the CA1 region of the rat hippocampus. Purinergic Signal., 6(Suppl 1), S101.
60. Ralevic, V. & Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
61. Rodrigues, R.J., Almeida, T., Richardson, P.J., Oliveira, C.R. & Cunha, R.A. (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J. Neurosci., 25, 6286-6295.
62. Roettger, V. & Lipton, P. (1996) Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience, 75, 677-685.
63. Rossi, D. & Volterra, A. (2009) Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull., 80, 224-232.
64. Rossi, D.J., Oshima, T. & Attwell, D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature, 403, 316-321.
65. Runden-Pran, E., Tanso, R., Haug, F.M., Ottersen, O.P. & Ring, A. (2005) Neuroprotective effects of inhibiting N-methyl-D-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation. Neuroscience, 136, 795-810.
66. Safiulina, V.F., Kasyanov, A.M., Sokolova, E., Cherubini, E. & Giniatullin, R. (2005) ATP contributes to the generation of network-driven giant depolarizing potentials in the neonatal rat hippocampus. J. Physiol., 565, 981-992.
67. Sawe, N., Steinberg, G. & Zhao, H. (2008) Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J. Neurosci. Res., 86, 1659-1669.
68. Siniscalchi, A., Cavallini, S., Marino, S., Falzarano, S., Franceschetti, L. & Selvatici, R. (2006) Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. Ann. N Y Acad. Sci., 1090, 445-454.
69. Somjen, G.G. (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev., 81, 1065-1096.
70. Sperlagh, B., Kofalvi, A., Deuchars, J., Atkinson, L., Milligan, C.J., Buckley, N.J. & Vizi, E.S. (2002) Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem., 81, 1196-1211.
71. Sperlagh, B., Vizi, E.S., Wirkner, K. & Illes, P. (2006) P2X7 receptors in the nervous system. Prog. Neurobiol., 78, 327-346.
72. Sweatt, J.D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol., 14, 311-317.
73. Szatkowski, M., Barbour, B. & Attwell, D. (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature, 348, 443-446.
74. Tanaka, E., Yamamoto, S., Kudo, Y., Mihara, S. & Higashi, H. (1997) Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J. Neurophysiol., 78, 891-902.
75. Thomas, G.M. & Huganir, R.L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci., 5, 173-183.
76. Tuttolomondo, A., Di Sciacca, R., Di Raimondo, D., Renda, C., Pinto, A. & Licata, G. (2009) Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr. Top. Med. Chem., 9, 1240-1260.
77. Verkhratsky, A., Krishtal, O.A. & Burnstock, G. (2009) Purinoceptors on neuroglia. Mol. Neurobiol., 39, 190-208.
78. Waetzig, V. & Herdegen, T. (2005) Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci., 26, 455-461.
79. Wang, X., Wang, H., Xu, L., Rozanski, D.J., Sugawara, T., Chan, P.H., Trzaskos, J.M. & Feuerstein, G.Z. (2003) Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J. Pharmacol. Exp. Ther., 304, 172-178.
80. Yamamoto, S., Tanaka, E., Shoji, Y., Kudo, Y., Inokuchi, H. & Higashi, H. (1997) Factors that reverse the persistent depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J. Neurophysiol., 78, 903-911.
81. Yin, H.Z., Sensi, S.L., Ogoshi, F. & Weiss, J.H. (2002) Blockade of Ca2+-permeable AMPA/kainite channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J. Neurosci., 22, 1273-1279.
82. Yu, C.Z., Li, C., Pei, D.S., Zong, Y.Y., Shi, Q., Wen, X.R., Guan, Q.H., Hang, D., Hou, X.Y. & Zhang, G.Y. (2009) Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction. Neurochem. Res., 34, 2008-2021.
83. Zeng, J.W., Liu, X.H., Zhang, J.H., Wu, X.G. & Ruan, H.Z. (2008) P2Y1 receptor-mediated glutamate release from cultured dorsal spinal cord astrocytes. J. Neurochem., 106, 2106-2118.
84. Zhuang, S. & Schnellmann, R.G. (2006) A death-promoting role for extracellular signal-regulated kinase. J. Pharmacol. Exp. Ther., 319, 991-997.